SU‐E‐T‐260: Risk of Second Cancer From Scattered Dose During the Radiation Therapy with Lung Cancer

D. Kim, W. Chung, D. Shin, S. Park, K. Chung, Myonggeun Yoon

Research output: Contribution to journalArticle

Abstract

Purpose: To compare the organ equivalent doses (OEDs) from scattered and leakage doses following intensity‐modulated radiotherapy (IMRT), volumetric arc therapy (VMAT) and tomotherapy (TOMO) in patients with lung cancer. Methods: IMRT, VMAT and TOMO were planned for the lung cancer patients. The OEDs are estimated from the measured corresponding secondary doses during irradiation at various points 20 to 80 cm from the iso‐center by using the radio‐photoluminescence glass dosimeter (RPLGD) on the surface. Results: The secondary dose per Gy from IMRT, VMAT and TOMO for lung cancer, measured 20 to 80 cm from the iso‐center, are less than 2.0, 1.5 and 1.0 cGy, respectively. The normalized mean values of relative OED of secondary dose of IMRT, VMAT and TOMO are 100%, 89% and 42% for thyroid, 100%, 82% and 42% for pancreas, 100%, 78% and 49% for bowel, 100%, 73% and 73% for rectum, 100%, 74% and 82% for prostate. The secondary dose and OED from TOMO became similar to those from IMRT and VMAT as the distance from the field edge increased. Conclusion: OED based estimation suggests that the secondary cancer risk from TOMO is less than or comparable to the risks from conventional IMRT and VMAT in patients with lung cancer.

Original languageEnglish
Pages (from-to)264
Number of pages1
JournalMedical Physics
Volume40
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Second Primary Neoplasms
Lung Neoplasms
Radiotherapy
Therapeutics
Rectum
Glass
Prostate
Pancreas
Thyroid Gland
Neoplasms

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐260 : Risk of Second Cancer From Scattered Dose During the Radiation Therapy with Lung Cancer. / Kim, D.; Chung, W.; Shin, D.; Park, S.; Chung, K.; Yoon, Myonggeun.

In: Medical Physics, Vol. 40, No. 6, 2013, p. 264.

Research output: Contribution to journalArticle

Kim, D. ; Chung, W. ; Shin, D. ; Park, S. ; Chung, K. ; Yoon, Myonggeun. / SU‐E‐T‐260 : Risk of Second Cancer From Scattered Dose During the Radiation Therapy with Lung Cancer. In: Medical Physics. 2013 ; Vol. 40, No. 6. pp. 264.
@article{ff15caffbfd34624951e16f8eeaa8ca6,
title = "SU‐E‐T‐260: Risk of Second Cancer From Scattered Dose During the Radiation Therapy with Lung Cancer",
abstract = "Purpose: To compare the organ equivalent doses (OEDs) from scattered and leakage doses following intensity‐modulated radiotherapy (IMRT), volumetric arc therapy (VMAT) and tomotherapy (TOMO) in patients with lung cancer. Methods: IMRT, VMAT and TOMO were planned for the lung cancer patients. The OEDs are estimated from the measured corresponding secondary doses during irradiation at various points 20 to 80 cm from the iso‐center by using the radio‐photoluminescence glass dosimeter (RPLGD) on the surface. Results: The secondary dose per Gy from IMRT, VMAT and TOMO for lung cancer, measured 20 to 80 cm from the iso‐center, are less than 2.0, 1.5 and 1.0 cGy, respectively. The normalized mean values of relative OED of secondary dose of IMRT, VMAT and TOMO are 100{\%}, 89{\%} and 42{\%} for thyroid, 100{\%}, 82{\%} and 42{\%} for pancreas, 100{\%}, 78{\%} and 49{\%} for bowel, 100{\%}, 73{\%} and 73{\%} for rectum, 100{\%}, 74{\%} and 82{\%} for prostate. The secondary dose and OED from TOMO became similar to those from IMRT and VMAT as the distance from the field edge increased. Conclusion: OED based estimation suggests that the secondary cancer risk from TOMO is less than or comparable to the risks from conventional IMRT and VMAT in patients with lung cancer.",
author = "D. Kim and W. Chung and D. Shin and S. Park and K. Chung and Myonggeun Yoon",
year = "2013",
doi = "10.1118/1.4814695",
language = "English",
volume = "40",
pages = "264",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐260

T2 - Risk of Second Cancer From Scattered Dose During the Radiation Therapy with Lung Cancer

AU - Kim, D.

AU - Chung, W.

AU - Shin, D.

AU - Park, S.

AU - Chung, K.

AU - Yoon, Myonggeun

PY - 2013

Y1 - 2013

N2 - Purpose: To compare the organ equivalent doses (OEDs) from scattered and leakage doses following intensity‐modulated radiotherapy (IMRT), volumetric arc therapy (VMAT) and tomotherapy (TOMO) in patients with lung cancer. Methods: IMRT, VMAT and TOMO were planned for the lung cancer patients. The OEDs are estimated from the measured corresponding secondary doses during irradiation at various points 20 to 80 cm from the iso‐center by using the radio‐photoluminescence glass dosimeter (RPLGD) on the surface. Results: The secondary dose per Gy from IMRT, VMAT and TOMO for lung cancer, measured 20 to 80 cm from the iso‐center, are less than 2.0, 1.5 and 1.0 cGy, respectively. The normalized mean values of relative OED of secondary dose of IMRT, VMAT and TOMO are 100%, 89% and 42% for thyroid, 100%, 82% and 42% for pancreas, 100%, 78% and 49% for bowel, 100%, 73% and 73% for rectum, 100%, 74% and 82% for prostate. The secondary dose and OED from TOMO became similar to those from IMRT and VMAT as the distance from the field edge increased. Conclusion: OED based estimation suggests that the secondary cancer risk from TOMO is less than or comparable to the risks from conventional IMRT and VMAT in patients with lung cancer.

AB - Purpose: To compare the organ equivalent doses (OEDs) from scattered and leakage doses following intensity‐modulated radiotherapy (IMRT), volumetric arc therapy (VMAT) and tomotherapy (TOMO) in patients with lung cancer. Methods: IMRT, VMAT and TOMO were planned for the lung cancer patients. The OEDs are estimated from the measured corresponding secondary doses during irradiation at various points 20 to 80 cm from the iso‐center by using the radio‐photoluminescence glass dosimeter (RPLGD) on the surface. Results: The secondary dose per Gy from IMRT, VMAT and TOMO for lung cancer, measured 20 to 80 cm from the iso‐center, are less than 2.0, 1.5 and 1.0 cGy, respectively. The normalized mean values of relative OED of secondary dose of IMRT, VMAT and TOMO are 100%, 89% and 42% for thyroid, 100%, 82% and 42% for pancreas, 100%, 78% and 49% for bowel, 100%, 73% and 73% for rectum, 100%, 74% and 82% for prostate. The secondary dose and OED from TOMO became similar to those from IMRT and VMAT as the distance from the field edge increased. Conclusion: OED based estimation suggests that the secondary cancer risk from TOMO is less than or comparable to the risks from conventional IMRT and VMAT in patients with lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=85024796958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024796958&partnerID=8YFLogxK

U2 - 10.1118/1.4814695

DO - 10.1118/1.4814695

M3 - Article

AN - SCOPUS:85024796958

VL - 40

SP - 264

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -